derived peptide (Tat), coupled to Maleimide-PEG2000-DSPE pegylated liposomal
doxorubicin (PLD) in many respects, including drug and liposome cellular delivery, drug
release, biodistribution, in vivo cell delivery and antitumor activity. The liposomes were
HePC-free and-containing liposomes, from which liposomes with 25, 50, 100 and 200
numbers of Tat/liposome were prepared. Similarly, DiI-C18 (3)-model liposomes (DiI-L and …